CRON Q1 2021 Earnings — Cronos Group Inc. Revenue & Financial Results | Market Cap Arena

CRONCronos Group Inc.

$983M

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16M+88.0% YoY

Gross Profit

-$4M-23.5% margin

Operating Income

-$57M-358.4% margin

Net Income

-$203M-1279.1% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

-7.0%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$54M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$393M

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$8M	+88.0%
Gross Profit	-$4M	-$6M	+42.5%
Operating Income	-$57M	-$45M	-26.1%
Net Income	-$203M	$76M	-366.6%

Revenue Segments

Cannabis Flower

$9M75%

Cannabis Extracts

$3M25%

Product and Service, Other

$33,0000%

Geographic Segments

CANADA

$8M60%

ISRAEL

$3M20%

UNITED STATES

$2M19%

Other Countries

$70,0001%